Summary

Host Cell Protein Testing Market Research Report Forecast till 2032

Market Overview
Host Cell Protein Testing Market is estimated to register a healthy CAGR of 5.73% during the review period. The developing Research and development exercises and advancements in the biopharmaceutical business are driving business sector development.
The host Cell Protein testing market is supposed to observe hearty development during the conjecture time frame, driven by elements, for example, expanding interest for biologics and biosimilars, developing commonness of ongoing infections, and reception of trend setting innovations for HCP testing. Also, central parts in the market are putting resources into Research and development exercises to foster new arrangements, as most would consider to be normal to additional fuel the market development.
The rise of constant and viral illnesses all over the planet has expanded use on Research and development drives. The medication improvement process is being advanced quickly by mechanical progression and development in biomedical sciences. This headway has sped up the advancement of medications and diminished the medication lifecycle period by 500 days. Also, instructive establishments and exploration associations are putting resources into the development of melded and useful proteins. The rising interests in drug solidness have expanded the interest for better host cell protein strategies. In addition, Researchers are exploring techniques to keep antibodies and proteins stable in natural conditions.
Moreover, the developing interest for protein-based antibodies to treat viral, bacterial, and other microorganism-based illnesses has energized worldwide exploration endeavors. The rising commonness of sicknesses, for example, paroxysmal nighttime hemoglobinuria and element VII and VIII inadequacy has helped examination into improved restorative and business protein producing. In this manner, during the gauge time frame, such open doors are projected to drive the host cell protein testing market.
Market Segmentation
Based on type, the Host Cell Protein Testing Market is divided into includes mass spectrometry-based assays, PCR-based assays, ELISA-based assays, and others.
The Host Cell Protein Testing Market segmentation is based on end user that include contract research organizations, biopharmaceutical companies, and others.
Regional Insights
The North America host cell protein testing market is likely to lead the host cell protein market in future. This is because of the rising number of clinical preliminaries, rising interest for creative medication for constant sicknesses, and expanding research for quality and cell treatment items in the North American region.
Europe host cell protein testing market represents the second-biggest piece of the pie because of a rising number of clinical preliminaries in nations like Germany, and France, profoundly embraced mechanically progressed items in biopharmaceutical businesses, and agreement research associations. further, Germany host cell protein testing market was credited to hold the biggest piece of the pie, and the France host cell protein testing market is supposed to quickest developing business sector in the European region.
Major Players
The major players in the Host Cell Protein Testing Market include Enzo Life Sciences, Inc (US), Bio-Rad Laboratories, Inc (US), Biogenes GmbH (Germany), Cisbio Bioassays (France), Abcam plc (UK), Thermo Fisher Scientific Inc (US), Cytiva (US), Cygnus Technologies, LLC (US), Rockland Immunochemicals, Inc (US), and Agilent Technologies, Inc (US).

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW

3.2 DATA FLOW

3.2.1 Data Mining Process

3.3 PURCHASED DATABASE:

3.4 SECONDARY SOURCES:

3.4.1 Secondary Research Data Flow:

3.5 PRIMARY RESEARCH:

3.5.1 Primary Research DATA FLOW:

3.5.2 Primary Research: Number Of Interviews Conducted

3.5.3 Primary Research: Regional Coverage

3.6 APPROACHES FOR MARKET SIZE ESTIMATION:

3.6.1 Revenue Analysis Approach

3.7 DATA FORECASTING

3.7.1 Data Forecasting Technique

3.8 DATA MODELING

3.8.1 Microeconomic Factor Analysis:

3.8.2 Data Modeling:

3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 DEVELOPMENTS IN THE BIOPHARMACEUTICAL INDUSTRY

4.2.2 Growing R&D Activities

4.3 RESTRAINTS

4.3.1 Issues Related To The Efficiency And Accuracy Of The Test Kits

4.4 OPPORTUNITY

4.4.1 Growing Technological Advancements

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D And Designing

5.1.2 Manufacturing

5.1.3 Distribution & Sales

5.1.4 Post-Sales Review

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 Bargaining Power Of Buyers

5.2.2 Bargaining Power Of Suppliers

5.2.3 Threat Of NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 Intensity Of Rivalry

5.3 IMPACT OF COVID-19

5.3.1 Impact On Supply Chain

5.3.2 Impact On Production

5.3.3 Impact On Demand-Supply Gap Analysis

5.4 TOTAL NUMBER OF SAMPLES RUN BY TYPE OF TECHNOLOGY (2022)

5.5 ANALYSIS OF REGULATORY LANDSCAPE BY REGION/COUNTRY

5.5.1 US

5.5.2 EMEA

6 GLOBAL HOST CELL PROTEIN TESTING MARKET, BY TYPE

6.1 OVERVIEW

6.1.1 PCR-Based Assays

6.1.2 ELISA-Based Assays

6.1.3 Mass Spectrometry-Based Assays

6.1.3.1 Liquid Chromatography–Mass Spectrometry (LC–MS)

6.1.3.2 Tandem Mass Spectrometry (MS/MS)

6.1.3.3 Others

6.1.4 Others

7 GLOBAL HOST CELL PROTEIN TESTING MARKET, BY END USER

7.1 OVERVIEW

7.1.1 Contract Research Organizations

7.1.2 Biopharmaceutical Companies

7.1.3 Others

8 GLOBAL HOST CELL PROTEIN TESTING MARKET, BY REGION

8.1 OVERVIEW

8.2 NORTH AMERICA

8.2.1 US

8.2.2 CANADA

8.3 EUROPE

8.3.1 Germany

8.3.2 France

8.3.3 UK

8.3.4 Italy

8.3.5 Spain

8.3.6 Rest Of Europe

8.4 ASIA-PACIFIC

8.4.1 CHINA

8.4.2 JAPAN

8.4.3 INDIA

8.4.4 AUSTRALIA

8.4.5 SOUTH KOREA

8.4.6 REST OF ASIA-PACIFIC

8.5 REST OF THE WORLD

8.5.1 MIDDLE EAST

8.5.2 AFRICA

8.5.3 LATIN AMERICA

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW

9.2 MARKET SHARE ANALYSIS, 2022

9.3 COMPETITOR DASHBOARD

9.4 PUBLIC PLAYERS STOCK SUMMARY

9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL

9.6 KEY DEVELOPMENTS & GREST OF THE WORLDTH STRATEGIES

9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

9.6.2 MERGER AND ACQUISITION

9.6.3 PARTNERSHIP/INVESTMENT/EXPANSION

10 COMPANY PROFILES

10.1 ENZO LIFE SCIENCES, INC

10.1.1 COMPANY OVERVIEW

10.1.2 FINANCIAL OVERVIEW

10.1.3 PRODUCTS OFFERED

10.1.4 KEY DEVELOPMENTS

10.1.5 SWOT ANALYSIS

10.1.6 KEY STRATEGIES

10.2 BIO-RAD LABORATORIES, INC

10.2.1 COMPANY OVERVIEW

10.2.2 FINANCIAL OVERVIEW

10.2.3 PRODUCTS OFFERED

10.2.4 KEY DEVELOPMENTS

10.2.5 SWOT ANALYSIS

10.2.6 KEY STRATEGIES

10.3 BIOGENES GMBH

10.3.1 COMPANY OVERVIEW

10.3.2 FINANCIAL OVERVIEW

10.3.3 PRODUCTS OFFERED

10.3.4 KEY DEVELOPMENTS

10.3.5 KEY STRATEGIES

10.4 CISBIO BIOASSAYS

10.4.1 COMPANY OVERVIEW

10.4.2 FINANCIAL OVERVIEW

10.4.3 PRODUCTS OFFERED

10.4.4 KEY DEVELOPMENTS

10.4.5 KEY STRATEGIES

10.5 ABCAM PLC

10.5.1 COMPANY OVERVIEW

10.5.2 FINANCIAL OVERVIEW

10.5.3 PRODUCTS OFFERED

10.5.4 KEY DEVELOPMENTS

10.5.5 KEY STRATEGIES

10.6 THERMO FISHER SCIENTIFIC INC

10.6.1 COMPANY OVERVIEW

10.6.2 FINANCIAL OVERVIEW

10.6.3 DISEASE TYPES OFFERed

10.6.4 KEY DEVELOPMENTS

10.6.5 SWOT ANALYSIS

10.6.6 Key Strategy

10.7 CYTIVA

10.7.1 COMPANY OVERVIEW

10.7.2 FINANCIAL OVERVIEW

10.7.3 Products OFFERed

10.7.4 KEY DEVELOPMENTS

10.7.5 SWOT Analysis

10.7.6 KEY STRATEGIES

10.8 CYGNUS TECHNOLOGIES, LLC

10.8.1 COMPANY OVERVIEW

10.8.2 FINANCIAL OVERVIEW

10.8.3 Products OFFERed

10.8.4 KEY DEVELOPMENTS

10.8.5 Key Strategy

10.9 ROCKLAND IMMUNOCHEMICALS, INC

10.9.1 COMPANY OVERVIEW

10.9.2 FINANCIAL OVERVIEW

10.9.3 DISEASE TYPES OFFERed

10.9.4 KEY DEVELOPMENTS

10.9.5 KEY STRATEGIES

10.10 AGILENT TECHNOLOGIES, INC

10.10.1 COMPANY OVERVIEW

10.10.2 FINANCIAL OVERVIEW

10.10.3 DISEASE TYPES OFFERed

10.10.4 KEY DEVELOPMENTS

10.10.5 SWOT ANALYSIS

10.10.6 KEY STRATEGIES

11 DATA CITATIONS

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT

TABLE 2 TOTAL NUMBER OF SAMPLES RUN BY TYPE OF TECHNOLOGY (2022)

TABLE 3 GLOBAL HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 4 GLOBAL HOST CELL PROTEIN TESTING MARKET, FOR PCR-BASED ASSAYS, BY REGION, 2019–2032 (USD BILLION)

TABLE 5 GLOBAL HOST CELL PROTEIN TESTING MARKET, FOR ELISA-BASED ASSAYS, BY REGION, 2019–2032 (USD BILLION)

TABLE 6 GLOBAL HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY REGION, 2019–2032 (USD BILLION)

TABLE 7 GLOBAL HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 8 GLOBAL HOST CELL PROTEIN TESTING MARKET, FOR LIQUID CHROMATOGRAPHY–MASS SPECTROMETRY (LC–MS), BY REGION, 2019–2032 (USD BILLION)

TABLE 9 GLOBAL HOST CELL PROTEIN TESTING MARKET, FOR TANDEM MASS SPECTROMETRY (MS/MS), BY REGION, 2019–2032 (USD BILLION)

TABLE 10 GLOBAL HOST CELL PROTEIN TESTING MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)

TABLE 11 GLOBAL HOST CELL PROTEIN TESTING MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)

TABLE 12 GLOBAL HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 13 GLOBAL HOST CELL PROTEIN TESTING MARKET, FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019–2032 (USD BILLION)

TABLE 14 GLOBAL HOST CELL PROTEIN TESTING MARKET, FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2019–2032 (USD BILLION)

TABLE 15 GLOBAL HOST CELL PROTEIN TESTING MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)

TABLE 16 GLOBAL: HOST CELL PROTEIN TESTING MARKET, BY REGION, 2019–2032 (USD BILLION)

TABLE 17 NORTH AMERICA: HOST CELL PROTEIN TESTING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)

TABLE 18 NORTH AMERICA: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 19 NORTH AMERICA: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 20 NORTH AMERICA: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 21 US: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 22 US: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 23 US: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 24 CANADA: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 25 CANADA: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 26 CANADA: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 27 EUROPE: HOST CELL PROTEIN TESTING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)

TABLE 28 EUROPE: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 29 EUROPE: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 30 EUROPE: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 31 GERMANY: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 32 GERMANY: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 33 GERMANY: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 34 FRANCE: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 35 FRANCE: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 36 FRANCE: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 37 UK: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 38 UK: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 39 UK: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 40 ITALY: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 41 ITALY: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 42 ITALY: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 43 SPAIN: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 44 SPAIN: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 45 SPAIN: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 46 REST OF EUROPE: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 47 REST OF EUROPE: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 48 REST OF EUROPE: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 49 ASIA-PACIFIC HOST CELL PROTEIN TESTING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)

TABLE 50 ASIA-PACIFIC: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 51 ASIA-PACIFIC: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 52 ASIA-PACIFIC: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 53 CHINA: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 54 CHINA: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 55 CHINA: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 56 JAPAN: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 57 JAPAN: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 58 JAPAN: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 59 INDIA: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 60 INDIA: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 61 INDIA: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 62 AUSTRALIA: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 63 AUSTRALIA: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 64 AUSTRALIA: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 65 SOUTH KOREA: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 66 SOUTH KOREA: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 67 SOUTH KOREA: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 68 REST OF ASIA-PACIFIC: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 69 REST OF ASIA-PACIFIC: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 70 REST OF ASIA-PACIFIC: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 71 REST OF THE WORLD: HOST CELL PROTEIN TESTING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)

TABLE 72 REST OF THE WORLD: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 73 REST OF THE WORLD: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 74 REST OF THE WORLD: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 75 MIDDLE EAST: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 76 MIDDLE EAST: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 77 MIDDLE EAST: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 78 AFRICA: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 79 AFRICA: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 80 AFRICA: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 81 LATIN AMERICA: HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019–2032 (USD BILLION)

TABLE 82 LATIN AMERICA: HOST CELL PROTEIN TESTING MARKET, FOR MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 83 LATIN AMERICA: HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 84 PUBLIC PLAYERS STOCK SUMMARY

TABLE 85 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL

TABLE 86 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 87 MERGER AND ACQUISITION

TABLE 88 PARTNERSHIP/INVESTMENT/EXPANSION/COLLABORATION

TABLE 89 ENZO LIFE SCIENCES, INC: PRODCUTS OFFERED

TABLE 90 BIO-RAD LABORATORIES, INC: PRODCUTS OFFERED

TABLE 91 BIO-RAD LABORATORIES, INC: KEY DEVELOPMENTS

TABLE 92 BIOGENES GMBH: PRODCUTS OFFERED

TABLE 93 BIOGENES GMBH: KEY DEVELOPMENTS

TABLE 94 CISBIO BIOASSAYS: PRODCUTS OFFERED

TABLE 95 ABCAM PLC: PRODCUTS OFFERED

TABLE 96 THERMO FISHER SCIENTIFIC INC: DISEASE TREATMENT OFFERED

TABLE 97 THERMO FISHER SCIENTIFIC INC: KEY DEVELOPMENTS

TABLE 98 CYTIVA: PRODCUTS OFFERED

TABLE 99 CYTIVA: KEY DEVELOPMENTS

TABLE 100 CYGNUS TECHNOLOGIES, LLC: PRODCUTS OFFERED

TABLE 101 CYGNUS TECHNOLOGIES, LLC: KEY DEVELOPMENTS

TABLE 102 ROCKLAND IMMUNOCHEMICALS, INC: DISEASE TREATMENT OFFERED

TABLE 103 AGILENT TECHNOLOGIES, INC: DISEASE TREATMENT OFFERED